Outcome data for two distinct implementation phases
| Primary and secondary outcome data of eligible cases | |||
| Phase 1 (n=1815) | Phase 2 (n=1394) | P value | |
| Number of babies whose TSBR was sent at least one time (%) | 882 (48.60%) | 236 (16.93%) | <0.001 |
| Number of TSBR performed | 1022 (56%) | 437 (31%) | <0.001 |
| Mean number of TSBR performed per baby | 1.2 (0.5) | 1.9 (1.2) | >1.000 |
| Number of babies requiring >1 TSBR (%) | 99 (11%) | 104 (44%) | <0.001 |
| Mean peak TSBR (SD) (mg/dl) | 9.22 (2.59) | 10.22 (3.25) | <0.001 |
| Phototherapy number (%) | 70 (4%) | 85 (6%) | 0.0017 |
| Number of babies whose TcBR was done at least one time | 0 | 1125 (81%) | – |
| Number of TcBR performed | 0 | 2956 | – |
| Mean number of TcBR performed per babies | 0 | 2.6 (1.2) | |
| Number of babies requiring >1 TcBR (%) | 0 | 847 (75%) | – |
| Mean peak TcBR (SD) (mg/dL) | 0 | 8.94 (2.29) | – |
| Total number of tests performed (TSBR+TcBR) | 1022 | 437+2956=3393 | NA |
In the post-implementation phase, 2956 TcBRs were performed. The mean peak TcBR among babies in phase 2 was 9.0±2.3 mg/dL.
TcBR, transcutaneous bilirubin; TSBR, total serum bilirubin.